The upgrade is a result of several factors, including the medical center’s dominant market position, strong profitability, solid liquidity metrics and improved leverage metrics. Fitch also acknowledged YRMC’s upcoming capital spending.
The outlook is stable.
More articles on healthcare finance:
12 hospitals seeking RCM talent
Biomedical Research Foundation’s lack of cash continues to worry state officials
U of Mass Medical School founds Institute for Rare Diseases Research with $10M gift from Chinese businessman
